Repositori institucional URV
Español Català English
TITLE:
Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer - imarina:6389321

URV's Author/s:BORRAS BALADA, JOAN LLUÍS / Correig Blanchar, Francesc Xavier / GUAITA ESTERUELAS, SANDRA / Gumà Padró, José / RODRÍGUEZ BALADA, MARTA / SAMINO GENÉ, SARA / Yanes Torrado, Óscar
Author, as appears in the article.:Roig B; Rodríguez-Balada M; Samino S; Lam E; Guaita-Esteruelas S; Gomes A; Correig X; Borràs J; Yanes O; Gumà J
Author's mail:oscar.yanes@urv.cat
jose.guma@urv.cat
xavier.correig@urv.cat
Author identifier:0000-0003-3695-7157
0000-0001-7541-9832
0000-0002-6902-3054
Journal publication year:2017
Publication Type:Journal Publications
ISSN:20452322
APA:Roig B; Rodríguez-Balada M; Samino S; Lam E; Guaita-Esteruelas S; Gomes A; Correig X; Borràs J; Yanes O; Gumà J (2017). Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer. Scientific Reports, 7(1), 17831-. DOI: 10.1038/s41598-017-17897-8
Papper original source:Scientific Reports. 7 (1): 17831-
Abstract:© 2017 The Author(s). Hereditary breast and ovarian cancer syndrome (HBOC) is partly due to the presence of mutations in the BRCA genes. Triple-negative (TN) breast cancer (BC) shares histological characteristics with germline BRCA1 mutation-associated tumours. We have investigated the metabolic profiles of human breast cancer (BC) cell lines carrying BRCA1 pathogenic mutations by non-targeted liquid chromatography coupled to mass spectrometry technology. Based on our in vitro results, we performed a targeted metabolomic analysis of plasma samples from TN HBOC patients taking into account their BRCA1 genotype. BRCA1 promoter hypermethylation and the BRCAness phenotype of BC cell lines were also studied. The purpose of this study was to determine the metabolic signature of HBOC syndrome and TNBC patients and to evaluate the potential contribution of the metabolites identified to the genetic diagnosis of breast cancer. The present results show the existence of a differential metabolic signature for BC cells based on the BRCA1 functionality. None of the studied BC cell lines presented hypermethylation of the BRCA1 promoter region. We provide evidence of the existence of free methylated nucleotides capable of distinguishing plasma samples from HBOC patients as BRCA1-mutated and BRCA1 non-mutated, suggesting that they might be considered as BRCA1-like biomarkers for TNBC and HBOC syndrome.
Article's DOI:10.1038/s41598-017-17897-8
Link to the original source:https://www.nature.com/articles/s41598-017-17897-8
Papper version:info:eu-repo/semantics/publishedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Enginyeria Electrònica, Elèctrica i Automàtica
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Thematic Areas:Zootecnia / recursos pesqueiros
Saúde coletiva
Química
Psicología
Odontología
Nutrição
Multidisciplinary sciences
Multidisciplinary
Medicina veterinaria
Medicina iii
Medicina ii
Medicina i
Materiais
Matemática / probabilidade e estatística
Letras / linguística
Interdisciplinar
Geografía
Geociências
Farmacia
Engenharias iv
Engenharias iii
Engenharias ii
Enfermagem
Educação física
Educação
Economia
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Ciências ambientais
Ciências agrárias i
Ciência de alimentos
Ciência da computação
Biotecnología
Biodiversidade
Astronomia / física
Entity:Universitat Rovira i Virgili
Record's date:2024-09-07
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili